by Raynovich Rod | Dec 11, 2022 | 2024 Rayno Biopharmaceuticals Portfolio
Update-2 Powell Reiterates Need To Fight Inflation The FED raised rates 50 bpts and Powell said more rate increases are coming, ( but aren’t we getting close to the top?). Stocks ended lower,NAZ down 0.75%, with gyrations in last 30 minute of trading. It was...
by Raynovich Rod | Nov 28, 2022 | 2024 Rayno Biopharmaceuticals Portfolio, Macro
Uncertainty Grips Markets- But December Still Looks Good Major Indices are down as of 11 am trading amid protest in China.Apple (AAPL) is down over 2% on potential production shortfall from Foxconn.The XBI is flat at thee $81 level but large caps are strong and the...
by Raynovich Rod | May 15, 2022 | 2024 Rayno Biopharmaceuticals Portfolio
May 25 -Update-3 ..We will take this little rally after all the turmoil recently. Our Strategy has not changed since January which is to stay with large cap biopharma stocks . We would like to pick some winners among the smaller cap biotech and diagnostics stocks but...
by Raynovich Rod | Sep 20, 2021 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio
Update 3…IBB teetering along SEP Support of $170: 9/24..A lot of red today XBI down 2%. Large caps down as well. BNTX down over 5%. Update-2 Another good day for life science stocks. Still expecting a Q4 biotech bounce in small/mid-cap stocks. FED Meeting...
by Raynovich Rod | Mar 8, 2021 | 2023-24 Life Science Portfolios, 2024 Rayno Biopharmaceuticals Portfolio
Update on rally day 3/9/21 1:22p Biotech and Healthcare Movers per Post Tech stocks rally on reversal trade. Biopharma positioned between value and moderate growth. COVID Vaccine stocks all up big BNTX CVAC NVAX MRNA. Small caps continue in uptrend ; IJR IWC IWM....
by Raynovich Rod | Jun 28, 2012 | BIOgraph, Biopharmaceuticals, Macro
Update 1 Mid-day Trading -June 29 Bulls Back in Charge on EU Bank Bailout The market has forgotten about Obamacare and reverted to the number one market issue-Euro debt resolution. Here is a healthcare sector update from today’s trading and our take:...